BlueCrest Capital Management’s Krystal Biotech KRYS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-9,280	Closed	-$305K	–	752
2019 Q1	$305K	Buy	+9,280	New	+$305K	0.01%	689